Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
activateTHR, AMC, andthe, andTHR, Annex, ATM, Baker, border, combat, comfortable, commerce, companion, couple, COVID, delivery, disability, disregarding, distancing, DMC, Enanta, Entertainment, equivalent, forty, GameStop, Genentech, home, hopeful, inactive, inTG, inTHR, leadproduct, Lilly, lp, media, midst, MRI, ofRegulation, ofTHR, onForm, onpage, outlook, overestimating, pace, pandemic, pathogenicity, pathologist, pause, PDFF, pravastatin, precautionary, proceed, procuring, quarantine, redirect, remotely, retirement, risky, school, shaped, simvastatin, site, Slightly, slower, spiked, staffing, supervisory, theTHR, thirty, tothe, travel, unemployment, unusual, variant, warfarin, withTHR
Removed:
accredited, activate, Aegerion, aggressive, agonism, alirocumab, Allergan, Amgen, anacetrapib, atherogenic, attack, blood, brain, circulating, classification, considerable, constantly, correlation, disorder, eprotirome, evolocumab, exceedingly, gemcabene, Gemphire, genetic, HoFH, incapable, inherited, lomitapide, metabolizing, mipomersen, molecule, monotherapy, mutation, onset, page, parent, particle, permitted, pipeline, placement, plc, pleoitropic, recycle, removing, scoring, stroke, structure, Tobira, vast
Filing tables
Filing exhibits
Related press release
MDGL similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-225434, 333-219304) and Form S-8 (Nos. 333-141903, 333-152824, 333-173862, 333-181117, 333-187243, 333-194477, 333-202680, 333-206128, 333-212615, 333-224503 and 333-249866) of Madrigal Pharmaceuticals, Inc. of our report dated February 25, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP |
Philadelphia, Pennsylvania |
February 25, 2021 |